Document:

<PAGE>

                                                            Exhibit 4.30

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE "ACT"). NO INTEREST IN THIS NOTE MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO
(i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, (ii) TO THE EXTENT
APPLICABLE, PURSUANT TO RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE
ACT), OR (iii) AN EXEMPTION FROM REGISTRATION UNDER THE ACT WHERE THE HOLDER HAS
FURNISHED TO THE PAYOR AN ACCEPTABLE OPINION OF ITS COUNSEL THAT AN EXEMPTION
PROM REGISTRATION UNDER THE ACT IS AVAILABLE.

                             ARCADIA RESOURCES, INC.
                      AMENDED AND RESTATED PROMISSORY NOTE

$17,000,000                                                        JUNE 25, 2007

     FOR VALUE RECEIVED, the undersigned, Arcadia Resources, Inc., a Nevada
corporation ('Payor"), having its executive office and principal place of
business at 26777 Central Park Boulevard, Suite 200, Southfield, Michigan 48076,
hereby promises to pay to JANA Master Fund, Ltd. ("Payee"), having an address at
200 Park Avenue, Suite 3300, New York, NY 10166, at Payee's address set forth
above (or at such other place as Payee may from time to-time hereafter direct by
notice in writing to Payor), the principal sum of SEVENTEEN MILLION DOLLARS
($17,000,000), in such coin or currency of the United States of America as at
the time shall be legal tender for the payment of public and private debts in
accordance with the terms hereof.

1.   PAYMENT OF PRINCIPAL AND INTEREST.

     1.1  The principal amount of this Note outstanding from time to time shall
          bear simple interest at the annual rate (the "Note Rate") equal to the
          One Year Libor Rate (as such rate is published in the Wall Street
          Journal) plus seven and one half percent (7.5%) from the date hereof
          ("Base Interest Rate") until the entire principal balance due under
          this Note has been paid in full; provided, however, that in the event
          the entire principal balance due under this Note has not been paid in
          full as of January 31, 2007, the Base Interest Rate shall increase by
          1% per month on the first day of each month beginning February 1,
          2007, not to exceed a maximum aggregate increase of 5% in total
          ("Interest Escalation Provision"). Notwithstanding anything contained
          herein to the contrary, the Note Rate on and after July 1, 2007 shall
          be equal to the One Year Libor Rate (as such rate is published in the
          Wall Street Journal) plus eight percent (8%). As of July 1, 2007, the
          Interest Escalation Provision shall be of no further force or effect
          and the applicable Note Rate shall be calculated without consideration
          of the Interest Escalation Provision. On and after the date which the
          total amount outstanding under this Note is equal to or less than
          Eight Million Five Hundred Thousand ($8,500,000) Dollars the Note Rate
          shall be equal to the One Year Libor Rate (as such rate is published
          in the Wall Street Journal) plus four percent (4%).

     1.2  The unpaid principal balance shall be due and payable on June 30, 2008

                                   Page 1 of 8

<PAGE>

          ("Maturity Date"). Accrued unpaid interest on the unpaid principal
          balance due under this Note shall be due and payable on June 30, 2007,
          and fifty percent (50%) of the accrued unpaid interest on the unpaid
          principal balance due under this Note shall be due and payable on the
          following dates: September 30, 2007; December 31, 2007; and March 31,
          2008. All remaining unpaid accrued interest shall be due and payable
          on the Maturity Date.

     1.3  If Payor prepays any portion of the principal amount due under this
          Note on or before December 30, 2006 ("Permitted Prepayment Date"),
          together with the unpaid interest thereon accrued through the date of
          such prepayment, Payor shall pay a prepayment fee equal to the One
          Year Libor Rate (as such rate is published in the Wall Street Journal
          on the date of such prepayment) plus one and one-half percent (1.5%).

     1.4  All payments (including prepayments) made by the Payor on this Note
          shall be applied first to the payment of accrued unpaid interest on
          this Note and then to the reduction of the unpaid principal balance of
          this Note.

     1.5  In the event that the date for the payment of any amount payable under
          this Note falls due on a Saturday, Sunday or public holiday under the
          laws of the State of New York, the time for payment of such amount
          shall be extended to the next succeeding business day and interest at
          the Note Rate shall continue to accrue on any principal amount so
          effected until the payment thereof on such extended due date.

2.   REPLACEMENT OF NOTE.

     2.1  In the event that this Note is mutilated, destroyed, lost or stolen,
          Payor shall, at its sole expense, execute, register and deliver a new
          Note, in exchange and substitution for this Note, if mutilated, or in
          lieu of and substitution for this Note, if destroyed, lost or stolen.
          In the case of destruction, loss or theft, Payee shall furnish to
          Payor indemnity reasonably satisfactory to Payor, and in any such
          case, and in the case of mutilation, Payee shall also furnish to Payor
          evidence to its reasonable satisfaction of the mutilation,
          destruction, loss or theft of this Note and of the ownership thereof.
          Any replacement Note so issued shall be in the same outstanding
          principal amount as this Note and dated the date to which interest
          shall have been paid on this Note or, if no interest shall have yet
          been paid, dated the date of this Note.

     2.2  Every Note issued pursuant to the provisions of Section 2.1 above in
          substitution for this Note shall constitute an additional contractual
          obligation of the Payor, whether or not this Note shall be found at
          any time or be enforceable by anyone.

3.   INTENTIONALLY OMITTED

4.   COVENANTS OF PAYOR.

                                   Page 2 of 8

<PAGE>

     Payor, on behalf of itself and its subsidiaries, covenants and agrees that,
     so long as this Note remains outstanding and unpaid, in whole, or in part:

     4.1  Payor and its subsidiaries will not sell, transfer or dispose of, nor
          permit or suffer the placement of any lien (statutory or other),
          priority, security interest, encumbrance or any other preferential
          arrangement upon, any of their material assets (including but not
          limited to real property and Payor's equity interests in such
          subsidiaries) without obtaining Payee's written consent, other than
          inventory in the ordinary course of business;

     4.2  Payor shall upon Payee's request furnish Payee with monthly financial
          updates;

     4.3  Payor and its subsidiaries will not pay any type of bonus to senior
          executive officers unless Payor's earnings before interest, taxes,
          depreciation and amortization ("EBITDA") for the fiscal year ending
          March 30, 2007 is greater than Eleven Million Dollars ($11,000,000) or
          Payee otherwise gives its written consent;

     4.4  Payor and its subsidiaries will not engage in sale/lease back
          transactions wherein real or personal property of Payor or its
          subsidiaries is sold and then reacquired in any type of lease
          transaction if the aggregate amount of all such transactions would
          exceed Five Million Dollars ($5,000,000);

     4.5  Payor and its subsidiaries will promptly pay and discharge all lawful
          taxes, assessments and governmental charges or levies imposed upon any
          of them, their income and profits, or any of their property, before
          the same shall become in default, as well as all lawful claims for
          labor, materials and supplies which, if unpaid, might become a lien or
          charge upon such properties or any part thereof; provided, however,
          that Payor or such subsidiary shall not be required to pay and
          discharge any such tax, assessment, charge, levy or claim so long as
          the validity thereof shall be contested in good faith by appropriate
          proceedings and Payor or such subsidiary, as the case may be, shall
          set aside on its books adequate reserves with respect to any such tax,
          assessment, charge, levy or claim so contested;

     4.6  Payor and its subsidiaries will do or cause to be done all things
          necessary to preserve and keep in full force and effect each of their
          corporate existence, rights and franchises and substantially comply
          with all laws applicable to them as their counsel may advise;

     4.7  Except with respect to any debt owing to Payee or the refinancing of
          any existing debt of Payor and/or its subsidiaries owing to Payee,
          Payor and its subsidiaries will not: (i) incur any obligation for
          borrowed money, any obligation evidenced by bonds, notes or similar
          instruments (including any obligations incurred in the acquisition of
          property, assets or business), any reimbursement obligation, any
          deferred purchase price obligation, any guarantees of any such
          obligations, or any similar obligations (collectively, "debt") which
          is senior or pari passu to the debt under this Note, or to which the

                                   Page 3 of 8
<PAGE>

          debt under this Note would be structurally subordinate, if such debt
          together with such existing debt of Payor and its subsidiaries would
          exceed Twenty Five Million Dollars ($25,000,000), without Payee's
          consent or (ii) incur debt junior to the debt under this Note in an
          aggregate amount which exceeds Twenty Five Million Dollars
          ($25,000,000), other than to the extent such junior debt is issued to
          finance acquisitions in the ordinary course of Payor or its
          subsidiaries' business, without Payee's consent;

     4.8  Payor and its subsidiaries will utilize the proceeds of any sale of
          any of real or personal property for any of: (i) additional capital
          expenditures, (ii) payment of any debt which is senior to the debt
          under this Note, or (iii) the payment of debt arising under this Note;

     4.9  Payor and its subsidiaries will not issue any form of equity or other
          security (other than debt) in a public or private placement capital
          raise without Payee's consent;

     4.10 Payor and its subsidiaries will at all times maintain, preserve,
          protect and keep each of their property used or useful in the conduct
          of business in good repair, working order and condition (except for
          the effects of reasonable wear and tear in the ordinary course of
          business) and will from time to time, make all necessary and proper
          repairs, renewals, replacements, betterments and improvements thereto;

     4.11 Payor and its subsidiaries will keep adequately insured, by
          financially sound reputable insurers, all property of a character
          usually insured by similar corporations and carry such other insurance
          as is usually carried by similar corporations;

     4.12 Payor will, promptly following the occurrence of an Event of Default
          or of any condition or event which, with the giving of notice or the
          lapse of time or both, would constitute an Event of Default, furnish a
          statement of Payor's Chief Executive Officer or Chief Financial
          Officer to Payee setting forth the details of such Event of Default or
          condition or event and the action which Payor intends to take with
          respect thereto; and

     4.13 Payor will, and will cause each of its subsidiaries to, at all times
          maintain books of account in which all of its financial transactions
          are duly recorded in conformance with generally accepted accounting
          principles.

5.   EVENTS OF DEFAULT. The following events each constitute an "Event of
     Default":

     5.1  The dissolution of Payor or any vote in favor thereof by the board of
          directors and shareholders of Payor; or

     5.2  Payor makes an assignment for the benefit of creditors, or files with
          a court of competent jurisdiction an application for appointment of a
          receiver or similar official with respect to it or any substantial
          part of its assets, or Payor files a petition seeking relief under any
          provision of the Federal Bankruptcy Code or any other federal or state
          statute now or hereafter in effect affording relief to

                                   Page 4 of 8

<PAGE>

          debtors, or any such application or petition is filed against Payor,
          which application or petition is not dismissed or withdrawn within
          sixty (60) days from the date of its filing; or

     5.3  Payor fails to pay the principal amount, or interest on, or any other
          amount payable under this Note within five (5) days of when the same
          becomes due and payable; or

     5.4  Payor admits in writing its inability to pay its debts as they mature;
          or

     5.5  Payor sells all or substantially all of its assets or merges or is
          consolidated with or into another corporation other than a transaction
          whose primary purpose is to re-domicile the Payor ; or

     5.6  A proceeding is commenced to foreclose a security interest or lien in
          any property or assets of Payor as a result of a default in the
          payment or performance of any debt (in excess of $350,000 and secured
          by such property or assets) of Payor or of any subsidiary of Payor; or

     5.7  A final judgment for the payment of money in excess of $350,000 is
          entered against Payor by a court of competent jurisdiction, and such
          judgment is not discharged (nor the discharge thereof duly provided
          for) in accordance with its terms, nor a stay of execution thereof
          procured, within sixty (60) days after the date such judgment is
          entered, and, within such period (or such longer period during which
          execution of such judgment is effectively stayed), an appeal therefrom
          has not been prosecuted and the execution thereof caused to be stayed
          during such appeal; or

     5.8  An attachment or garnishment is levied against the assets or
          properties of Payor or any subsidiary of Payor involving an amount in
          excess of $350,000 and such levy is not vacated, bonded or otherwise
          terminated within sixty (60) days after the date of its effectiveness;
          or

     5.9  Payor or any subsidiary defaults in the due observance or performance
          of any covenant, condition or agreement to be observed or performed
          pursuant to the terms of this Note (other than the default specified
          in Section 5.3above) and such default continues uncured for a period
          of thirty (30) days from the date Payor receives written notice from
          the Payee; or

     Upon the occurrence of any such Event of Default and at any time
     thereafter, the holder of this Note shall have the right (at such holder's
     option) to declare the principal of, accrued unpaid interest on, and all
     other amounts payable under this Note to be forthwith due and payable,
     whereupon all such amounts shall be immediately due and payable to the
     holder of this Note, without presentment, demand, protest or other notice
     of any kind, all of which are hereby expressly waived; provided.

6.   SUITS FOR ENFORCEMENT AND REMEDIES.

     6.1  If any one or more Events of Default shall occur and be continuing,
          the Payee

                                   Page 5 of 8

<PAGE>

          may proceed to (1) protect and enforce Payee's rights either by suit
          in equity or by action at law, or both, whether for the specific
          performance of any covenant, condition or agreement contained in this
          Note or in any agreement or document referred to herein or in aid of
          the exercise of any power granted in this Note or in any agreement or
          document referred to herein, (ii) enforce the payment of this Note, or
          (iii) enforce any other legal or equitable right of the holder of this
          Note. No right or remedy herein or in any other agreement or
          instrument conferred upon the holder of this Note is intended to be
          exclusive of any other right or remedy, and each and every such right
          or remedy shall be cumulative and shall be in addition to every other
          right and remedy given hereunder or now or hereafter existing at law
          or in equity or by statute or otherwise.

7.   UNCONDITIONAL OBLIGATION; FEES, WAIVERS, OTHER.

     7.1  The obligation to make the payments provided for in this Note are
          absolute and unconditional and are not subject to any defense,
          set-off, counterclaim, rescission, recoupment or adjustment
          whatsoever.

     7.2  If, following the occurrence of an Event of Default, Payee shall seek
          to enforce the collection of any amount of principal of and/or
          interest on this Note, there shall be immediately due and payable from
          Payor, in addition to the then unpaid principal of, and accrued unpaid
          interest on, this Note, all reasonable costs and expenses incurred by
          Payee in connection therewith, including, without limitation,
          reasonable attorneys' fees and disbursements.

     7.3  No forbearance, indulgence, delay or failure to exercise any right or
          remedy with respect to this Note shall operate as a waiver or as an
          acquiescence in any default, nor shall any single or partial exercise
          of any right or remedy preclude any other or further exercise thereof
          or the exercise of any other right or remedy.

     7.4  This Note may not be modified or discharged (other than by payment)
          except by a writing duly executed by Payor and Payee.

     7.5  Payor hereby expressly waives demand and presentment for payment,
          notice of nonpayment, notice of dishonor, protest, notice of protest,
          bringing of suit, and diligence in taking any action to collect
          amounts called for hereunder, and shall be directly and primarily
          liable for the payment of all sums owing and to be owing hereon,
          regardless of and without any notice, diligence, act or omission with
          respect to the collection of any amount called for hereunder or in
          connection with any right, lien, interest or property at any and all
          times which Payee had or is existing as security for any amount called
          for hereunder.

8.   Intentionally Deleted.

9.   Intentionally Deleted.

10.  Intentionally Deleted.

                                   Page 6 of 8

<PAGE>

11.     MISCELLANEOUS.

     11.1 The headings of the various paragraphs of this Note are for
          convenience of reference only and shall in no way modify any of the
          terms or provisions of this Note.

     11.2 All notices required or permitted to be given hereunder shall be in
          writing and shall be deemed to have been duly given when personally
          delivered or sent by registered or certified mail (return receipt
          requested, postage prepaid), facsimile transmission or overnight
          courier to the address of the intended recipient as set forth in the
          preamble to this Note or at such other address as the intended
          recipient shall have hereafter given to the other party hereto
          pursuant to the provisions of this Note.

     11.3 This Note and the obligations of Payor and the rights of Payee shall
          be governed by and construed in accordance with the substantive laws
          of the State of New York without giving effect to the choice of laws
          rules thereof.

     11.4 This Note shall bind Payor and its successors and assigns.

     11.5 Except with respect to any sale of inventory in the ordinary course of
          business, Payor shall deliver to Payee, within 30 days of collection,
          50% of the Net Proceeds of all sales of assets occurring after June
          25, 2007 up to $10,000,000 in total asset sales and 75% of the Net
          Proceeds of all sales of assets after June 25, 2007 to the extent the
          aggregate Net Proceeds of all such asset sales exceed $10,000,000. The
          payment of Net Proceeds, as provided in this Section, shall not be
          required to the extent the amount of such payment would exceed the
          total amount outstanding under this Note. For purposes of this
          section, the term "Net Proceeds" shall mean the actual cash amount
          collected by Payor in consideration of the asset sale less any costs,
          expenses, taxes or other amounts incurred by Payor as a result of the
          asset sale. "Net Proceeds" shall not include any interest paid to
          Payor as a result of an asset sale.

     11.6 This Note amends, supersedes and restates in its entirety that certain
          Note dated November 30, 2006, given by Payor to Payee, in the
          principal amount of $21 million (the "November 30, 2006 Note"), which
          November 30, 2006 Note is hereby rendered null and void.

                                        ARCADIA RESOURCES, INC.

                                        By: /s/ Marvin Richardson
                                            ------------------------------------
                                            Marvin Richardson
                                        Its: President and Chief Executive
                                             Officer

                                   Page 7 of 8

<PAGE>

Accepted and Agreed to:

JANA MASTER FUND, LTD.

BY: ITS INVESTMENT ADVISOR, JANA PARTNERS LLC

By: /s/ Marc Lehman
    ---------------------------------
    Marc Lehmann
Its: Partner

                                   Page 8 of 8<PAGE>

                                                                   Exhibit 10.65

                    AMENDED AND RESTATED EMPLOYMENT AGREEMENT

     THIS AMENDED AND RESTATED AGREEMENT ("Agreement") is made as of the
effective date designated below ("Effective Date"), by and between Care Clinic,
Inc., a Delaware corporation, ("Employer") and the undersigned individual
("Employee") and amends, restates and supersedes the Employment Agreement
originally made by Employer and Employee as of the Effective Date. Arcadia
Resources, Inc. ("KAD"), a Nevada corporation and parent of Employer, joins in
the execution of this Agreement solely for purposes of Section 3(I) herein.

                                    RECITALS

     Subject to the terms of this Agreement, Employer desires to employ, or
continue the employment of, Employee in the position(s) set forth herein, and
Employee desires to accept such employment.

     NOW, THEREFORE, in consideration of the recitals and covenants herein and
other valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Parties hereto agree as follows:

     1. EMPLOYMENT. Beginning on the Effective Date, Employer agrees to employ,
or to continue the employment of, Employee and Employee hereby accepts such
employment, subject to and contingent on the terms specified herein.

     2. DUTIES AND RESPONSIBILITIES. Employee shall serve in the position(s)
designated below on a full-time basis and shall report to Employer's Chairman of
the Board. Employer may hereafter change Employee's reporting relationships upon
obtaining Employee's written consent which shall not be unreasonably withheld.
Employee shall perform such duties and responsibilities as are consistent with
and required by such position(s) held by Employee and/or assigned by Employer
and subject to Employer's policies and procedures applicable to its employees
generally. Employee agrees to use Employee's best efforts to perform any and all
such duties and responsibilities necessary or appropriate to perform the
functions of such position(s). Employee shall have the right to determine the
location at which such employment services will be provided. While employed by
Employer, Employee agrees not to work for any other business or enterprise,
whether as an employee, agent, independent contractor or in any other capacity
whatsoever, except that Employee may pursue two patents pending as of the
Effective Date, a project involving authoring a book/associated website, a local
pharmacy project in the New York City metropolitan area, and may volunteer with
the Wellness Community, a 501 (c)(3) not for profit company provided that
Employee otherwise fulfills Employee's obligations to Employer. For purposes of
this Agreement, all matters requiring or permitting the agreement, consent, or
other determination or action of Employer shall be made by Employer's Board of
Directors or Employer's Chairman of the Board.

     3. COMPENSATION AND BENEFITS. Employer agrees to pay and provide Employee,
and Employee agrees to accept in full consideration for Employee's services to
Employer, the following:

                                  Page 1 of 18

<PAGE>

     A. SALARY. An annual base salary in the amount designated below ("Annual
Base Salary"), less applicable withholdings, payable in accordance with the
normal payroll practices of Employer. Employee's Annual Base Salary may be
increased by Employer from time to time in the discretion of Employer's Board of
Directors and will be subject to annual review by the Board of Directors.

     B. VACATION AND SICK TIME. Employee shall be entitled to take four (4)
weeks of paid vacation per year, plus a limited amount of paid time off for
sickness, disability, or other personal reasons in accordance with the
Employer's general time-off policies in effect from time to time for its
employees. There is no cash payment for unused vacation and other unused paid
time off benefits. Unused vacation and other unused paid time off benefits do
not carry over from year to year.

     C. FRINGE BENEFITS/RETIREMENT PLAN. Employee shall be entitled to health
care benefits, and additionally to participate in such additional fringe
benefits and qualified retirement plans and other plans offered by Employer to
its employees generally from time to time, in accordance with Employer's
eligibility and participation provisions of such plans.

     D. EXPENSE REIMBURSEMENT. The Employer shall reimburse Employee all
reasonable out-of-pocket expenses incurred by Employee in connection with the
performance of duties hereunder and upon Employee's submission of such receipts
and records as Employer requires to evidence such expenses.

     E. ANNUAL BONUS. Employer's Board of Director's, in its discretion, will
establish an annual Employee bonus plan.

     F. BOARD POSITION. During the term of Employee's employment, and provided
that during such term of employment the Employee Management Team (as hereinafter
defined) owns fifteen (15%) percent or greater of the combined holdings of
common stock of Employer owned by the Employee's Management Team and KAD,
Employee shall be designated to serve on the Board of Directors of Care Clinic,
Inc.

     G. D& O INSURANCE. During the term of Employee's employment and for a
period of three years thereafter, Employer shall at all times keep in place a
directors and officers' liability insurance policy (or policies).

     H. INDEMNIFICATION. The Employer agrees that (i) if the Employee is made a
party, or is threatened to be made a party, to any proceeding by reason of the
fact that he is or was a director, officer, employee, agent or representative of
the Employer or was serving at the request of Employer as a director, officer,
employee, agent or representative of another person or entity or (ii) if any
claim is made, or threatened to be made, that arises out of or relates to the
Employee's service in any of the foregoing capacities, then the Employee shall
promptly be indemnified and held harmless by the Employer to the fullest extent
legally permitted or authorized by the Employers' certificate of incorporation,
bylaws or board of directors resolutions or, if greater, by the laws of the
State of Florida, against any and all costs, expenses, liabilities and losses

                                  Page 2 of 18

<PAGE>

(including without limitation, attorney's fees, judgments, interest, expenses of
investigation, penalties, fines, and amounts paid or to be paid in settlement)
incurred or suffered by the Employee in connection herewith, if the Employee
acted in good faith and in a manner he or she reasonably believed to be in, or
not opposed to, the best interests of the Employer and, with respect to any
criminal action or proceeding, had no reasonable cause to believe the Employee's
conduct was unlawful, and such indemnification shall continue as to the Employee
even if the Employee has ceased to be a director, officer, employee, agent, or
representative of the Employer or any other person or entity and shall inure to
the benefit of the Employers heirs, executors and administrators. Employer shall
advance to the Employee all costs and expenses reasonably incurred by the
Employee in connection with a proceeding or claim within fifteen (15) days after
receiving written notice of such costs and expenses and requesting such an
advance. Such notice shall include an undertaking by the Employee to repay the
amount advanced if the Employee is ultimately determined not to be entitled to
indemnification against such costs and expenses. For the purposes of this
Agreement, "proceeding" shall mean any threatened or actual action, suit, or
proceeding (whether civil, criminal, administrative, investigative, appellate or
other) and "claim" shall mean any claim, demand, request, investigation,
dispute, controversy, threat, discovery request, or request for testimony or
information.

Notwithstanding the foregoing, indemnification or advancement of expenses shall
not be made to or on behalf of the Employee, if a judgment or other final
adjudication establishes that Employee's actions, or omissions to act, were
material to the cause of action so adjudicated and constitute:

(a) A violation of the criminal law, unless the Employee had reasonable cause to
believe Employee's conduct was lawful or had no reasonable cause to believe
Employee's conduct was unlawful;

(b) A transaction from which the Employee derived an improper personal benefit
within the scope of Section 831 of the Florida Business Corporation Act;

(c) A circumstance under which the liability provisions of Section 834 (unlawful
distributions) of the Florida Business Corporation Act are applicable; or

(d) Willful misconduct or a willful disregard for the best interests of the
Employer in a proceeding by or in the right of the Employer to procure a
judgment in its favor.

Notwithstanding anything in this Agreement to the contrary, Employee shall not
be entitled to the rights of indemnification provided in this Section 3(H) in
the event that Employee's employment is terminated by Employer for cause
pursuant to Section 4(c)(i), 4(c)(ii) or 4(c)(iii) as a result of said event.

     I. EQUITY COMPENSATION. KAD restricted shares of common stock (the "KAD
Restricted Shares"), and the Care Clinic, Inc. restricted shares of common stock
(the "CCI Restricted Shares") as referenced herein are sometimes referred to
individually as a "Security" or collectively as the "Securities." All Securities
shall be non-assessable and subject to the same rights, privileges, preferences
and distributions as the same class of Securities held by other holders. The
term "Issuer" shall mean Arcadia Resources, Inc.

                                  Page 3 of 18

<PAGE>

in the case of the KAD Restricted Shares and shall mean Care Clinic, Inc. in the
case of the CCI Restricted Shares. The term "CCI Divestiture" shall mean the
acquisition of the beneficial ownership under the Securities Exchange Act of
1934 of 51% percent or more of the voting securities of Care Clinic, Inc., from
the shares of CCI common stock held by KAD, or all or substantially all of CCI's
assets, by a single person or entity or a group of affiliated persons or
entities unaffiliated with Arcadia Resources, Inc. or Care Clinic, Inc.

     (1)  KAD Restricted Shares. Conditioned and contingent on compliance by
          Employee with all terms and conditions specified in this Agreement,
          Employee will be awarded 800,000 KAD Restricted Shares which are
          restricted as to transferability and additionally subject to
          forfeiture in the event that Employee is not employed by the Employer
          as of each vesting date (the "Vesting Date") in subsection (a),
          subject to subsections (b) and (c) below. Employee will acquire rights
          as a shareholder in the KAD Restricted Shares upon each Vesting Date.
          Vested Securities shall not be subject to forfeiture under any
          circumstance or for any reason.

          a.   Vesting. Subject to acceleration or forfeiture as specified in
               section (1) immediately above and subject to subsections (b) and
               (c) below, the Employee's KAD Restricted Shares shall vest in
               four (4) equal installments as follows:

               (1)  25% of the Employee's KAD Restricted Shares shall vest on
                    April 1, 2007;

               (2)  An additional 25% of the Employee's KAD Restricted Shares
                    shall vest on April 1, 2008;

               (3)  An additional 25% of the Employee's KAD Restricted Shares
                    shall vest on April 1, 2009; and

               (4)  An additional 25% of the Employee's KAD Restricted Shares
                    shall vest on April 1, 2010; on which date all of the
                    Employee's KAD Restricted Shares shall be vested.

          b.   Accelerated Vesting. All of the Employee's KAD Restricted Shares,
               other than those forfeited, shall vest immediately upon the first
               to occur of (a) a Change in Control, or (b) the CCI Divestiture,
               provided that Employee is employed by Employer as of either such
               event.

          c.   Accelerated Vesting in the Event of a Termination Without Cause.
               In the event that Employee's Employment is terminated by Employer
               without cause prior to the occurrence of any of the events set
               forth in Section I(1)(b) above (the "Early Termination"), the
               Employee's KAD Restricted Shares shall vest as follows:

                                  Page 4 of 18

<PAGE>

               (1)  In the event that an Early Termination occurs prior to April
                    1, 2007, 25% of the Employee's KAD Restricted Shares shall
                    vest; and

               (2)  In the event that an Early Termination occurs on or after
                    April 1, 2007, an additional 6.25% of the Employee's KAD
                    Restricted Shares shall vest as of the last day of each
                    fiscal quarter completed thereafter prior to termination of
                    Employee's employment.

          d.   Availability of KAD Shares for Other Management Employees and
               Future Hires. KAD agrees that an aggregate of 2,026,471 shares of
               KAD Restricted Shares ("Management KAD Restricted Shares") shall
               be reserved for award to up to six CCI management level employees
               including Employee, and that an additional 150,000 shares of KAD
               common stock shall be reserved for future CCI hires.
               Collectively, the 2,176,471 shares shall be known as the
               "Management KAD Restricted Shares." Employee has to the right to
               determine the awardees that shall be entitled to the Management
               KAD Restricted Shares and the amount of such awards in Employee's
               sole discretion and subject to KAD Board or Board Compensation
               Committee approval which shall not be unreasonably withheld. A
               list of the current awardees is set forth as Exhibit A.
               Collectively, the employees entitled to receive the Management
               KAD Restricted Shares and the CCI Restricted Shares shall be
               known as the "Employee Management Team." To the extent that any
               of the Management KAD Restricted Shares do not vest, they will
               become immediately available for future grants to future hires in
               the Employment Management Team in Employee's sole discretion and
               subject to KAD Board or Board Compensation Committee approval
               which shall not be unreasonably withheld.

     (2)  CCI Restricted Shares. Conditioned and contingent on compliance by
          Employee with all terms and conditions specified in this Agreement,
          Employee will be awarded or will be permitted to purchase 44,000
          shares of shares of CCI common stock which are restricted as to
          transferability and additionally subject to forfeiture in the event
          that Employee is not employed by the Employer as of each vesting date
          (the "Vesting Date") in section (a) below. Employee will acquire
          rights as a shareholder in the CCI Restricted Shares upon each Vesting
          Date.

          a.   Vesting. Subject to forfeiture, the Employee's CCI Restricted
               Shares shall vest in two (2) equal installments as follows:

               (1)  50% of the Employee's CCI Restricted Shares shall vest on
                    September 1, 2007; and

                                  Page 5 of 18

<PAGE>

               (2)  An additional 50% of the Employee's CCI Restricted Shares
                    shall vest on September 1, 2008, on which date all of the
                    Employee's CCI Restricted Shares shall be vested.

          b.   Transferability Restriction and KAD Right of First Refusal. Prior
               to the consummation of the CCI Divestiture, Employee agrees not
               to sell or otherwise transfer any interest in any of the CCI
               Restricted Shares to any third party, except as follows: (i)
               Employee shall first present the opportunity to KAD in writing
               the ("Sale Notice") and (ii) KAD, in its discretion, may elect to
               purchase the CCI Restricted Shares on the same terms and
               conditions as presented or, if KAD does not choose to purchase
               the CCI Restricted Shares, it shall give its written consent to
               the proposed sale or other transfer within ten (10) business days
               of receipt of the Sale Notice. Except as set forth herein,
               Employee agrees not to sell or otherwise transfer any interest in
               any of the CCI Restricted Shares to any third party prior to the
               consummation of the CCI Divestiture. Notwithstanding the
               foregoing and subject to the other terms and conditions of this
               Agreement, Employee may transfer Employee's CCI Restricted
               Shares, in the case of Employee's death, by will or the laws of
               descent and distribution or, during Employee's lifetime, to
               Employee's "family member" (as defined in Form S-8) through gift
               or domestic relations order as permitted by Form S-8 (as
               currently in effect or as it may be amended).

          c.   Employee Put Right. In the event the CCI Divestiture is not
               consummated by September 1, 2008 and provided that Employee is
               then and remains employed by CCI through the closing date
               referenced below, and that the holders of a majority of the CCI
               Restricted Shares held by the Employee Management Team then
               employed by Employer has given KAD written notice obligating KAD
               to purchase all of their CCI Restricted Shares at a price equal
               to the fair market value per share, as of the last day of the
               fiscal quarter most recently ended before the date of Employee's
               notice, determined by an independent appraisal, Employee may also
               then give Kad written notice to purchase all Employee's CCI
               Restricted Shares at the same time for the same valuation. The
               appraiser shall be appointed by and mutually acceptable to KAD
               and Employee, which acceptance shall not be unreasonably
               withheld. KAD and Employee shall share equally in the cost of the
               appraisal and hereby agree to be bound by the valuation
               determined thereby. At its election, KAD may pay up to 50% of the
               purchase price in shares of KAD stock, with the balance paid in
               cash at closing. KAD and Employee shall reasonably cooperate to
               complete and close the sale and purchase within 120 days of the
               date of Employee's notice to KAD.

                                  Page 6 of 18

<PAGE>

          d.   Shareholding Position. KAD agrees that prior to consummation of
               the CCI Divestiture, up to 1,000,000 shares of CCI common stock
               shall be authorized and issued, with up to 110,000 shares being
               held by the Employee Management Team including Employee and an
               additional 40,000 shares of CCI common stock being reserved for
               future employees (collectively, the 150,000 CCI Restricted Shares
               shall be known as the "Management CCI Restricted Shares.").
               Employee has the right to determine the awardees that shall be
               entitled to receive the Management CCI Restricted Shares and the
               amounts of such awards in Employee's sole discretion and subject
               to CCI Board approval which shall not be unreasonably withheld. A
               list of the current awardees is set forth as Exhibit A. To the
               extent that any of the Management CCI Restricted Shares do not
               vest, they will become immediately available for future grants to
               future hires in the Employee Management Team in Employee's sole
               discretion and subject to KAD Board or Board Compensation
               Committee approval which shall not be unreasonably withheld").

     (3)  Nature of Securities. All Management KAD Restricted Shares shall be
          issued pursuant to the Arcadia Resources, Inc. 2006 Equity
          Compensation Plan or other available plan contingent on and subject to
          approval by KAD's shareholders and listing on AMEX, and compliance
          with all terms and conditions specified therein. KAD represents and
          warrants that the 2006 Equity Compensation Plan and the Management KAD
          Restricted Shares to be issued thereunder are approved by the KAD
          Board of Directors. KAD represents that it shall use its best efforts
          to fully comply with all applicable AMEX rules and regulations
          relative to issuance of the KAD Restricted Shares.

     (4)  Change in Control. "Change in Control" shall mean, for purposes of
          this Agreement, the occurrence of any of the following: (i)
          reorganization, merger or consolidation with an unaffiliated entity
          and in which KAD is not the surviving corporation, (ii) a sale of all
          or substantially all of the assets of KAD to another person
          unaffiliated with Arcadia Resources, Inc. or Care Clinic, Inc., (iii)
          the acquisition of beneficial ownership (within the meaning of Rule
          13d-3 under the Exchange Act) of an aggregate of 25% or more of the
          voting power of KAD's outstanding voting securities by any single
          person or group (as such term is used in Rule 13d-5 under the Exchange
          Act.

     (5)  Registration of Securities. Arcadia Resources, Inc. agrees to file
          with the U.S. Securities and Exchange Commission a registration
          statement within six months from the execution of this Agreement on
          form S-8 or such other form as Arcadia may be eligible to register the
          award and resale of the KAD Restricted Shares and to comply with the
          undertakings specified by the Commission's rules relative to the
          filing of post-effective

                                  Page 7 of 18

<PAGE>

          amendments for such registration form. Employee agrees that all sales
          and transfers of any interest in the KAD Restricted Shares shall be
          made in compliance with applicable federal and state law, this
          Agreement and KAD's policies on insider trading in effect from time to
          time applicable to employees of KAD and its subsidiaries which shall
          not be arbitrarily applied and which generally prohibit trading ten
          calendar days before the end of a fiscal quarter through the first
          trading day after KAD's earnings release or as determined by KAD due
          to an individual's possession of material, non-public information. In
          the event that Employee seeks to sell, assign, transfer or otherwise
          dispose of Securities on the basis of an exemption from registration
          under the Securities Act of 1933, as amended, and under the provisions
          of applicable state law, Employee shall provide to Arcadia, at
          Employee's cost, an opinion of Employee's counsel reasonably
          acceptable to the effect that the transaction is exempt from
          registration, and Arcadia shall issue appropriate instructions to its
          transfer agent at no cost necessary to effectuate the sale.

     (6)  Adjustments Upon Changes in Capitalization. In the event of changes in
          the outstanding securities of the Issuer by reason of distributions,
          dividends, splits, reverse splits, recapitalizations, mergers,
          consolidations, combinations or exchanges of units or shares,
          reorganizations, or liquidations, the number of Securities to be
          issued pursuant to the KAD Restricted Shares and the CCI Restricted
          Shares shall be correspondingly adjusted, so that Employee's
          proportionate interest in the Issuer, any successor thereto, or in the
          cash, assets or other securities into which the Securities are
          converted or exchanged, shall be maintained to the same extent, as
          near as may be practicable, as immediately before the occurrence of
          any such event. Furthermore, in the event of offerings of shares of
          common stock of CCI or any other securities which shall be convertible
          into shares of common stock of CCI for a purchase price up to Twenty
          ($20,000,000) Million Dollars, the number of Employee's CCI Restricted
          Shares shall be correspondingly adjusted, so that Employee's
          proportionate interest in the Issuer, any successor thereto, or in the
          cash, assets or other securities into which the Securities are
          converted or exchanged, shall be maintained to the same extent, as
          near as may be practicable, as immediately before the occurrence of
          any such sale; provided, however, that this provision shall not apply
          to subsequent offerings after the Twenty ($20,000,000) Million Dollar
          threshold is reached; and further provided that if the first such
          offering exceeds Twenty ($20,000,000) Million Dollars, the preceding
          anti-dilution provision shall apply.

     (7)  Non-Transferability of the Securities. Subject to any express terms
          and conditions of this Agreement to the contrary, the Securities shall
          not be transferable until each restriction specified herein shall
          terminate. Notwithstanding the foregoing and subject to the other
          terms and conditions of this Agreement, Employee may transfer
          Employee's

                                  Page 8 of 18

<PAGE>

          Securities, in the case of Employee's death, by will or the laws of
          descent and distribution or, during Employee's lifetime, to Employee's
          "family member" (as defined in Form S-8) through gift or domestic
          relations order as permitted by Form S-8 (as currently in effect or as
          it may be amended). Upon the vesting of the Securities pursuant to the
          Vesting Schedules herein, the Employee shall be entitled to sell the
          Securities subject to and in compliance with all applicable federal
          and state securities laws, the terms of this Agreement and KAD's
          policies on insider trading in effect from time to time applicable to
          employees of KAD and its subsidiaries which shall not be arbitrarily
          applied and which generally prohibit trading ten calendar days before
          the end of a fiscal quarter through the first trading day after KAD's
          earnings release or as determined by KAD due to an individual's
          possession of material, non-public information.

     (8)  Award Agreements. The KAD Restricted Shares and the CCI Restricted
          Shares shall be evidenced by award agreements and such other documents
          and terms as Employer shall require the are consistent with the terms
          described in this Agreement.

     (9)  Tax Obligations and Withholdings. Employee shall be responsible for
          all tax obligations arising from the Securities awarded hereunder.
          Employee shall cooperate as Employer deems necessary for the
          withholding of taxes.

     4. TERMINATION OF EMPLOYMENT AND OBLIGATION UPON TERMINATION OF EMPLOYMENT.
Employee's term of employment shall commence on the Effective Date and shall
continue until terminated as follows:

          A. TERMINATION WITHOUT CAUSE. Employer may terminate the Employee
     without cause upon ten (10) business days written notice. If the Employer
     terminates Employee's employment without cause, Employer shall pay Employee
     the unpaid Annual Base Salary and benefits earned and accrued, plus all
     unreimbursed expenses through such date, plus the Employer shall pay, as
     severance, an amount equal to (i) six (6) months of Employee's Annual Base
     Salary at the rate in effect on the date of termination, if employment
     terminates within one year of the Effective Date of this Agreement, and
     (ii) an amount equal to twelve (12) months of Employee's Annual Base Salary
     at the rate in effect on the date of termination, if employment terminates
     after the completion of one year from the Effective Date of this Agreement
     or thereafter. Such severance amount, less applicable withholdings, shall
     be paid over six (6) months if Employee is terminated pursuant to Section
     4A(i) or twelve (12) months if Employee is terminated pursuant to Section
     4A(ii), respectively, following the termination of Employee's employment in
     accordance with Employer's normal payroll practices. No interest shall be
     paid on the severance amounts set forth in this paragraph. Termination
     without cause shall include a termination by the Employer due to the
     failure of Employee to fully achieve all of any one or more, including any
     subpart, of the applicable annual Management by Objectives ("MBO") goals
     specified in the Addendum (attached to this Agreement and incorporated
     herein by this reference) or as the same may be amended in writing by
     Employer and Employee.

                                  Page 9 of 18

<PAGE>

          B. TERMINATION UPON DEATH OR DISABILITY. Employee's employment
     hereunder shall terminate upon the death or disability of the Employee. For
     purposes of this Agreement, "Disability" of the Employee will be deemed to
     have occurred whenever the Employee has suffered physical or mental
     illness, injury, or infirmity that prevents the Employee from performing,
     with or without reasonable accommodation, the Employee's essential job
     functions under this Agreement for a period of ninety (90) consecutive
     days; provided that the ninety (90) day period shall be available to
     Employee only once during any twenty-four month period. In the event of a
     termination due to death or Disability, Employer shall be obligated to pay
     Employee or Employee's estate, the amount of any unpaid Annual Base Salary
     earned and accrued through the date of termination, together with any
     unreimbursed expenses.

          C. TERMINATION FOR CAUSE. Employee's employment may be terminated by
     the Employer for cause upon written notice from the Employer specifying in
     detail the particular events and circumstances upon which the Employer is
     relying in terminating Employee's employment for cause. The Employee shall
     have ten (10) business days following receipt of the written notice to
     correct such events and circumstances. In the event that Employee does not
     correct such events and circumstances at the end of the ten (10) day notice
     period, he may be terminated for cause, If the Employer terminates Employee
     for cause, it shall only be obligated to pay Employee the amount of any
     unpaid Annual Base Salary earned and accrued through the date of
     termination, together with any unreimbursed expenses. For the purposes of
     this agreement "cause" means any of the following:

               (i) The conviction by Employee of any crime involving moral
     turpitude;

               (ii) The conviction by Employee of, or pleading guilty or no
     contest to, any crime, whether or not involving the Employer, constituting
     a felony in the jurisdiction involved, which Employer, in its sole
     discretion, determines may have an injurious effect on it;

               (iii) The Employee's gross negligence, willful misconduct,
     insubordination, or the willful and repeated failure or refusal to perform
     such duties as may be properly delegated to Employee by Employer hereunder;
     or

               (iv) The Employee's failure to act in the best interest of the
     Employer consistent with Employee's fiduciary dute as defined by law or the
     non-performance of Employee's duties provided such duties are normally
     associated with Employee's position and not violative of applicable laws,
     provided, however, that termination hereunder for cause shall not include a
     termination by the Employer due to Employee's failure to fully achieve all
     of any one or more, including any subpart, of the applicable annual MBO
     goals per Section 4(A).

          D. TERMINATION FOR GOOD REASON. Employee may terminate this Agreement
     for "Good Reason" at any time by written notice to the Employer. "Good
     Reason" shall be limited to the following circumstances: (i) a material
     breach of this Agreement by the Employer which is not cured after ten days
     written notice to the

                                  Page 10 of 18

<PAGE>

     Employer, (ii) a reduction by the Employer in the base salary of Employee,
     or (iii) a dissolution or liquidation of the Employer; (iv) failure to
     maintain Employee in a position commensurate with that referred to in
     Section 2 of this Agreement and/or changing Employee's title as set forth
     in "Employee Specific Information" of this Agreement without Employee's
     written consent which shall not be unreasonably withheld; or (v) the
     assignment to the Employee of any duties inconsistent with the Employee's
     position, authority, duties or responsibilities as contemplated by this
     Agreement, or any other action by Employer which results in a diminution of
     such position, authority, duties or responsibilities, or which materially
     impair the Employer's ability to function in his position, without first
     obtaining Employee's written consent which shall not be unreasonably
     withheld. In the event that the Employee terminates this Agreement for Good
     Reason, he shall be entitled to receive the severance payments set forth in
     Section 4A, except that, unless the Employee can demonstrate that he is not
     a "specified employee" as that term is defined in Section 409A(a)(2)(B)(i)
     of the Code (as hereinafter defined) when he invokes this section, it shall
     be presumed that the Employee is a "specified employee" for purposes of
     Code Section 409A and amounts due the Employee under this section shall be
     delayed as required by Code Section 409A(a)(2)(B)(i).

          E. RESIGNATION BY THE EMPLOYEE. The Employee may resign at any time
     upon thirty (30) days written notice. In the event of a resignation by the
     Employee, the Employer shall only be obligated to pay Employee the amount
     of any unpaid Annual Base Salary earned and accrued through the date of
     termination, together with any unreimbursed expenses.

          F. NO FURTHER OBLIGATIONS. Upon the termination of Employee's
     employment, Employer shall have no further liability or obligation
     whatsoever to Employee or Employee's personal representative, estate,
     heirs, beneficiaries, or any other person claiming by, under or through
     Employee, except as stated in such Sections.

     5. . PROHIBITION ON ACCELERATION OF BENEFITS. Benefits paid pursuant tot
this Section 4 shall in no event be accelerated except as specifically set forth
herein.

     6. INVENTIONS. If any at time during the term of Employee's employment,
Employee shall, either alone or with others, make, devise, create, invent or
discover any inventions, improvements, modifications, developments, ideas,
products, property, formulas, know-how, designs, models, processes, prototypes,
sketches, drawings, plans or other matters whatsoever (whether or not capable of
being protected by letters of patent, registration, copyright, registered
trademark, service marks or other protection) which, in any manner, relate to,
arise out of, or are in connection with the present or future business prospects
or activities of Employer relative to the medical clinic business conducted by
Employer including retail store walk-in clinics, corporate relationships, and
strategic alliances with health systems, providers and others (collectively
"Inventions"), all such Inventions shall immediately be and remain the sole and
exclusive property of Employer and Employee shall immediately and confidentially
communicate a description of the Invention to Employer and to no other party at
any time, and if Employer so desires, Employee shall execute all documents and
instruments and do all things as may be requested by Employer in order to
forever vest all right, title and interest in such

                                  Page 11 of 18

<PAGE>

Invention solely in Employer and to obtain such letters of patent, copyrights,
registrations or other protections as Employer may, from time to time, desire.

     7. CONFIDENTIALITY. Employee acknowledges and agrees that at all times
during and following the termination of employment with Employer under any
circumstances, Employee shall not use or disclose (i) any information, knowledge
or data relating in any way to the business, financial condition, sales, public
and private sources of financing, sales, customers, operations, suppliers,
products, services, Inventions, business relationships, manufacturing,
technologies or services of Employer, or (ii) any other proprietary or
confidential information, knowledge, data or details of the past, present or
future business affairs or practices of Employer (items (i) and (ii) are
hereafter referred to as "Confidential Information"), except Employee may use
any such Confidential Information provided to Employee as necessary solely
during the term of Employee's employment for the sole purpose of carrying out
Employee's duties hereunder for Employer's benefit provided Employee takes
adequate measures to protect the confidentiality thereof. Employee covenants and
agrees that (i) the use and disclosure restrictions applicable to Confidential
Information shall also apply to all documents or other materials containing any
Confidential Information ("Confidential Materials"), (ii) all Confidential
Materials are and shall remain at all times the sole exclusive property of
Employer and (iii) upon termination of employment, Employee shall promptly
return all Confidential Materials, and all copies and extracts thereof, to
Employer and at no time shall any Confidential Materials be used, copied,
published, circulated or disclosed, in any manner whatsoever, except as
specifically authorized herein other otherwise in writing by Employer. The term
"Confidential Information" does not include information which (i) is or becomes
generally available to the public other than by breach of this provision, (ii)
the Employee learns from a third party who is not under an obligation of
confidence to the Employer or a client of the Employer, or (iii) that the
Employer becomes legally obligated to disclose.

     8. COVENANT-NOT-TO-COMPETE. Employee covenants and agrees that during the
term of employment and for the two (2) year period following the resignation by
Employee or termination of employment for cause or the one (1) year period
following a termination without cause, due to disability, or for good reason
(the "Restricted Period"), Employee shall not, within the greater of any State
or Territory of the United States or a 50 mile radius of any location of the
Employer or its affiliates at which Employee worked or for which Employee had
managerial or other executive responsibility while employed by Employer
(collectively the "Restricted Area"), in any manner, directly or indirectly,
through intermediaries or other persons or entities, either as owner,
shareholder, director, officer, manager, member, agent, consultant, creditor,
representative, investor, partner, employee, or on behalf of any other person or
entity, or in any other capacity whatsoever (excepting Employee's passive
ownership of less than 5% of the securities of a publicly traded entity) (i)
engage in, assist, provide capital, services, advice or information to, or in
any manner whatsoever become associated with any business or enterprise that
offers products or services competitive with any business conducted by the
Employer or its affiliates, (ii) contact for any business purpose, solicit or
attempt to solicit any supplier, customer, agent, representative or employee of
Employer or its affiliates, or otherwise interfere with or attempt in any manner
to disrupt any relationship or agreement between Employer or its affiliates and
any of its customers, employees, agents, representatives or others doing
business with Employer or its affiliates, or (iii) compete with Employer or its
affiliates ("Restricted Activities"), provided that during the Restricted
Period, nothing herein shall prohibit Employee

                                  Page 12 of 18

<PAGE>

from engaging in any aspect of pharmacy business including specialty, mail
service, retail, benefits administration and the like. Employee agrees that any
Restricted Activities outside the Restricted Area with respect to or directly or
indirectly relating to any portion of the Restricted Area shall be deemed
conducted within the Restricted Area and prohibited hereby. As used herein,
"affiliates" shall include Employer's affiliated agencies and direct or indirect
subsidiaries or other business ventures, and shall further include Arcadia
Resources, Inc. ("Arcadia"), its subsidiaries and affiliated agencies thereof,
provided that the "business" of Arcadia, its subsidiaries and affiliated
agencies thereof shall be understood to mean the business of such entities as
conducted as of the date of this Agreement. It is further agreed that the
"business" of Employer shall be understood to mean and include Employer's
business relative to medical clinics in various settings including retail store,
corporate relationships, and strategic alliances with health systems and other
providers, and such other businesses as Employer establishes through the Term of
employment. Employee acknowledges and agrees that the legal consideration for
Employee's agreement to Sections 6, 7, 8 and 9 of this Agreement include
Employee's initial or continued employment hereunder, any equity compensation
which Employer agrees to award or cause to be awarded to Employee, and
Employer's agreement to pay severance compensation in the circumstances
described herein, and that Sections 6, 7, 8 and 9 of this Agreement shall be
enforceable by Employer's successors and assigns.

     9. ENFORCEABILITY. Employee expressly agrees and acknowledges that a loss
arising from a breach of any provision under Sections 6, 7, and 8 may not be
reasonably and equitably compensated by money damages. Therefore, Employee
agrees that in a case of any such breach, Employer shall be entitled to
injunctive and/or other extraordinary relief in order to prevent Employee from
engaging in any of the foregoing prohibited activities, which relief shall be
cumulative and in addition to any and all other additional remedies to which
Employer may be entitled to at law or equity. In the event that any court of
competent jurisdiction shall determine that any part or all of the provisions of
Sections 6, 7, and 8 are unenforceable or invalid due to the scope of the
activities restrained, the geographical extent of the restraints imposed, the
duration of the restraints imposed, or otherwise, the parties hereby expressly
intend, agree and stipulate that under such circumstances, the provisions of
Sections 6, 7, and 8 shall be enforceable to the fullest extent and scope
permitted by law and that the parties shall be bound by any judicial
modifications to the provisions therein which said court of competent
jurisdiction may make in order to carry out the intentions of the parties as
provided herein.

     10. GOVERNING LAW AND ARBITRATION. This Agreement and all disputes arising
out of Employee's employment shall be governed by and construed in accordance
with the laws of the State of Florida, notwithstanding the fact that either
party hereto is or may hereafter become domiciled or located in a different
state. Any dispute, controversy or claim arising out of or relating to this
Agreement or Employee's employment, whether arising in contract, tort or
otherwise, including all claims assertable under any federal or state law
prohibiting discrimination in employment, shall be resolved at arbitration in
accordance with the rules of the American Arbitration Association, except for
any equitable or injunctive relief sought by Employer under this Agreement and
any claims for workers' compensation benefits or compensation and any claims for
unemployment compensation benefits. There shall be a single, neutral arbitrator.
The arbitration shall be held at a location within Collier County, Florida, and
Employer agrees to pay Employee's reasonable travel expenses incurred in
connection therewith. The parties hereto agree that any arbitration award
rendered on any claim submitted to arbitration

                                  Page 13 of 18

<PAGE>

shall be final and binding upon the parties and not subject to appeal and that
judgment may be entered upon any arbitration award by any circuit court located
in Florida or by any other court of competent jurisdiction. The parties hereto
agree that the expenses of any arbitration (including the administrative charges
of the American Arbitration Association, as well as the fees and expenses paid
to the arbitrator selected to hear the case) shall be borne equally by the
parties to the proceeding, provided that each party shall bear its own attorneys
fees and cost of its own experts, evidence and the like. Employee acknowledges
and agrees that by making this agreement to submit all claims to binding
arbitration, Employee hereby waives the right to litigate in a court of law, and
to trial by jury if applicable, all claims against Employer, including all
claims assertable under any federal or state law prohibiting discrimination in
employment, except for any claims for workers' compensation benefits or
compensation and any claims for unemployment compensation benefits. Notice of
the demand for arbitration relating to any dispute or claim related to or
alleged to have arisen during the Term of employment shall be given in writing
to the other party to this Agreement no later than the expiration of six (6)
months following the expiration or termination of the Term, and as to all other
disputes or claims within six (6) months from the date the party asserting the
claim should reasonably have been aware of the same but in no event later than
the period specified by the applicable statute of limitations period. The
failure to give such notice shall operate to then bar any action, liability and
damages arising from or related to such alleged dispute or claim, with the same
force and effect as if the applicable statute of limitations had expired.

     11. WAIVER OF BREACH. The waiver of breach of any provision of this
Agreement shall not operate or be construed as a waiver of any subsequent
breach. Each and every right, remedy and power hereby granted to any party
hereto or allowed it by law shall be cumulative and not exclusive of any other.

     12. SEVERABILITY. If any of the provisions of this Agreement or the
application thereof to any party under any circumstances is adjudicated to be
invalid or unenforceable, such invalidity or unenforceability shall not affect
any other provision of this Agreement or the application thereof.

     13. INTERPRETATION OF AGREEMENT. Where appropriate in this Agreement, words
used in the singular shall include the plural, and words used in the masculine
shall include the feminine and neuter. All headings that are used in this
Agreement are for the convenience of the reader only and shall not be used to
limit or construe any of the provisions hereof.

     14. SURVIVAL OF PROVISIONS. The obligations of Employee under Sections 6,
7, 8 and 9 of this Agreement are continuing and shall survive the termination of
Employee's employment under any circumstances whatsoever.

     15. AMENDMENT OF AGREEMENT. The terms and provisions of this Agreement may
be altered or amended in any of their provisions only by the signed written
agreement of the parties hereto.

     16. SUCCESSORS. The Agreement shall inure to the benefit of Employer and
its successors and assigns, including but not limited to the provisions of
Sections 6, 7, 8 and 9, but may not be assigned or delegated by Employee as it
requires Employee's personal services.

                                  Page 14 of 18

<PAGE>

     17. ENTIRE AGREEMENT. This Agreement constitutes the entire agreement
between the parties with respect to the subject matter hereof and supersedes any
and all other previous or contemporaneous communications, term sheets,
representations, understandings, agreements, negotiations and discussions,
either oral or written, between the parties. The parties acknowledge and agree
that there are no prior or contemporaneous written or oral agreements,
understandings, or representations, directly or indirectly related to this
Agreement that are not set forth herein.

     18. COUNTERPART/FACSIMILE SIGNATURES. This Agreement may be executed in two
or more counterparts and by facsimile signature, each of which shall be deemed
an original, and all of which together shall constitute one and the same
Agreement.

     19. NOTICES. All notices sent or required to be sent hereunder shall be
sent by facsimile, or by overnight courier or by registered or certified mail,
postage prepaid, addressed as follows:

          To Employer:   Chairman of the Board
                         Care Clinic, Inc.
                         405 5th Avenue South, Suite 6
                         Naples, FL 34102
                         (239) 434-8884
                         Fax: (239) 434-5858

          To Employee:   At the address designated below

or to such address of which notice as aforesaid has previously been given, and
shall be deemed to have been given when so mailed.

     20. IRS SECTION 409A COMPLIANCE. Notwithstanding anything herein to the
contrary, to the extent any payment under any provision of this Agreement shall
be required to be delayed for a period of six months following the effective
date of termination of employment to comply with the "specified employee" rules
of Section 409A of the Internal Revenue Code of 1986, as amended (the "Code"),
it shall be so delayed (but not more than is required to comply with such
rules). The parties hereto acknowledge that in addition to any delay required
hereunder, it may be desirable, in view of regulations or other guidance issued
by the IRS under Section 409A of the Code, to amend provisions of the Agreement
to avoid the acceleration of tax or the imposition of additional tax or
penalties under Section 409A of the Code and that the Employer will not
unreasonably withhold its consent to any such amendments which in its
determination are (i) feasible and necessary to avoid adverse tax consequences
under Section 409A of the Code for Employee, and (ii) not adverse to the
interests of the Employer.

                          EMPLOYEE SPECIFIC INFORMATION

<TABLE>
<S>                           <C>
Employee                      Alan M. Lotvin, M.D.
Effective Date of Agreement   September 26, 2006
</TABLE>

                                  Page 15 of 18

<PAGE>

<TABLE>
<S>                           <C>
Position                      President and Chief Executive Officer,
                              Care Clinic, Inc.
Annual Base Salary            $250,000.00 per annum
Employee Mailing Address
</TABLE>

     The parties have executed this Agreement effective as of the Effective
Date.

                                        ----------------------------------------
                                        EMPLOYEE SIGNATURE

ACCEPTED BY EMPLOYER:

CARE CLINIC, INC., a Delaware corporation

By:
    ---------------------------------
    John E. Elliott, II
Its: Chairman of the Board

ARCADIA RESOURCES, INC.,
a Nevada corporation, which joins in the
execution of this Agreement solely for
purposes of Section 3(I) of this Agreement

By:
    ---------------------------------

Its:
     --------------------------------

                                  Page 16 of 18

<PAGE>

                                    ADDENDUM
            CARE CLINIC, INC. MANAGEMENT BY OBJECTIVES ("MBO") GOALS

SEPTEMBER 1, 2006 THROUGH MARCH 31, 2007

1)   Raise capital in an amount determined by Employer which is required for
     Care Clinic to open clinics in 300 locations by end of 2009

2)   Open clinics in cumulative total of 80 locations

3)   Completely define business and operational models for all three clinic
     types, SOP's, manuals, business development pipelines, medical oversight,
     compliance, etc., acceptable to Employer

APRIL 1, 2007 THROUGH MARCH 31, 2008

1)   Open clinics in cumulative total of 120 locations

2)   Revenue target to be agreed upon in writing between Employer and Employee

3)   EBITDA target to be agreed upon in writing between Employer and Employee

4)   Operating margin target to be agreed upon in writing between Employer and
     Employee for stores open greater than 12 months

APRIL 1, 2008 THROUGH MARCH 31, 2009

1)   Open clinics in cumulative total of 220 locations

2)   Revenue target to be agreed upon in writing between Employer and Employee

3)   EBITDA target to be agreed upon in writing between Employer and Employee

4)   Operating margin target to be agreed upon in writing between Employer and
     Employee for stores open greater than 12 months

APRIL 1, 2009 THROUGH MARCH 31, 2010

1)   Open clinics in cumulative total of 321 locations

2)   Revenue target to be agreed upon in writing between Employer and Employee

3)   EBITDA target to be agreed upon in writing between Employer and Employee

4)   Operating margin target to be agreed upon in writing between Employer and
     Employee for stores open greater than 12 months

OTHER

     All goals and objectives specified herein are subject to approval by the
Arcadia Resources, Inc. The assessment of achievement or non-achievement of each
annual MBO Goal

                                  Page 17 of 18

<PAGE>

shall be determined by Employer within 45 days of the end of each fiscal quarter
or within such additional time as Employer may reasonably require. All terms and
conditions of this Addendum are subject to all terms and conditions of
Employee's Employment Agreement and as the same may be amended from time to time
in writing mutually agreed to by Employer and Employee.

ACCEPTED AND AGREED:

-------------------------------------   ----------------------------------------
Employee                                For Care Clinic, Inc.

                                  Page 18 of 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]